Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter Clinical Study to Evaluate the Safety and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Subjects With Glaucoma

NCT06822738 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT06822738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06822738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter Clinical Study to Evaluate the Safety and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Subjects With Glaucoma
Lead sponsor
AbbVie
Phase
Phase 3
Overall status
Recruiting
Start date
February 11, 2025
Completion date
November 30, 2028
Enrollment
130 (estimated)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

primary open angle glaucoma